Yong Fu Chen
Director of Finance/CFO at Shenyang Sunshine Pharmaceuticals Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bin Huang | M | 63 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 31 years |
| Jing Lou | M | 61 |
Hongkong Sansheng Medical Ltd.
 Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong.
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 29 years |
| Dong Mei Su | M | 54 |
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong.
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 31 years |
| Bo Tan | M | 51 |
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong.
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 15 years |
| Ke Li | M | 56 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 31 years |
| Hui Dang | F | 52 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 25 years |
| Hui Hui Li | F | 43 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 11 years |
| Yan Li Liu | F | 43 |
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | 10 years |
| Xin Ma | M | 58 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shi Hong Liu | M | - |
Liaoning University
| 4 years |
| Bao Sheng He | M | 50 |
Liaoning University
| 4 years |
| Han Lin Zhang | M | 70 |
Liaoning University
| 4 years |
| Ying Shi | M | 61 |
Liaoning University
| 4 years |
| Qing Jie Guan | M | 65 |
Liaoning University
| 4 years |
| Bao Shan Wang | M | 69 |
Liaoning University
| 4 years |
| Yu Kun Zhang | F | 68 |
Liaoning University
| 4 years |
| Xin Fa Liu | M | 65 |
Liaoning University
| 4 years |
| Dong Lü | M | 49 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | - |
| Xue Zhi Liu | M | 60 |
Liaoning University
| 4 years |
| Zhonghua Zhang | M | 49 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | - |
| Shi Qiang Ban | M | 58 |
Liaoning University
| 4 years |
| Bin Wang | M | 69 |
Liaoning University
| 4 years |
| Ying Wang | F | - |
Liaoning University
| 4 years |
| Chun Shan Li | M | 72 |
Liaoning University
| 4 years |
| Yue Zhou | F | 60 |
Liaoning University
| 4 years |
| Bao Wei Sun | M | 61 |
Liaoning University
| 4 years |
| Wen Xiang Xing | M | 61 |
Liaoning University
| 4 years |
| Zhuo Xia | M | 58 |
Liaoning University
| 4 years |
| Su Ning Tian | M | 61 |
Liaoning University
| 4 years |
| Guo Jun Xing | M | 65 |
Liaoning University
| 4 years |
| Qing Jie Zhao | M | 67 |
Liaoning University
| 4 years |
| Yeng Xu Cui | M | 61 |
Liaoning University
| 4 years |
| Wei Qiang Wang | M | 76 |
Liaoning University
| 4 years |
| Zhi Le Wang | M | 76 |
Liaoning University
| 4 years |
| Zhong Zhi Ma | M | 80 |
Liaoning University
| 4 years |
| Sheng Li Wang | M | 74 |
Liaoning University
| 4 years |
| Ya Jun Du | M | 67 |
Liaoning University
| 4 years |
| Chuang Gao | M | 70 |
Liaoning University
| 27 years |
| Yue Hua Li | M | 63 |
Liaoning University
| 4 years |
| Xin Tian | M | 60 |
Liaoning University
| 4 years |
| Xing Bo Gao | M | 60 |
Liaoning University
| 4 years |
| Bao Hua Kang | M | 71 |
Liaoning University
| 4 years |
| Bing Wen Zheng | M | - |
Liaoning University
| 4 years |
| Dong Liu | M | 51 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | - |
| Jun Sheng Li | M | 63 |
Liaoning University
| 4 years |
| Guo Chen Liu | M | 67 |
Liaoning University
| 4 years |
| Ming Yu Chen | M | 61 |
Liaoning University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 46 | 97.87% |
| Hong Kong | 4 | 8.51% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Yong Fu Chen
- Personal Network
